GMED - Globus Medical, Inc.

NYSE - NYSE Delayed Price. Currency in USD
29.40
+0.40 (+1.38%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close29.00
Open29.05
Bid0.00 x 0
Ask0.00 x 0
Day's Range29.00 - 29.55
52 Week Range19.25 - 34.03
Volume523,914
Avg. Volume675,418
Market Cap2.83B
Beta0.99
PE Ratio (TTM)26.49
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • See what the IHS Markit Score report has to say about Globus Medical Inc.
    Markit9 days ago

    See what the IHS Markit Score report has to say about Globus Medical Inc.

    Short interest is moderate for GMED with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, ETFs holding GMED are favorable, with net inflows of $3.38 billion.

  • Capital Cube14 days ago

    Globus Medical, Inc. – Value Analysis (NYSE:GMED) : October 4, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Globus Medical, Inc. a score of 66. Our analysis is based on comparing Globus Medical, Inc. with the following peers – Stryker Corporation, K2M Group Holdings, Inc., Zimmer Biomet Holdings, Inc., NuVasive, Inc., Exactech, Inc., Orthofix International NV, RTI Surgical, Inc. and Alphatec Holdings, Inc. (SYK-US, KTWO-US, ... Read more (Read more...)

  • Globus Medical, Inc. breached its 50 day moving average in a Bullish Manner : GMED-US : October 3, 2017
    Capital Cube15 days ago

    Globus Medical, Inc. breached its 50 day moving average in a Bullish Manner : GMED-US : October 3, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Globus Medical, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)

  • See what the IHS Markit Score report has to say about Globus Medical Inc.
    Markit20 days ago

    See what the IHS Markit Score report has to say about Globus Medical Inc.

    Short interest is moderate for GMED with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.

  • See what the IHS Markit Score report has to say about Globus Medical Inc.
    Markit29 days ago

    See what the IHS Markit Score report has to say about Globus Medical Inc.

    Short interest is moderate for GMED with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.

  • Globus Medical, Inc. breached its 50 day moving average in a Bearish Manner : GMED-US : September 14, 2017
    Capital Cubelast month

    Globus Medical, Inc. breached its 50 day moving average in a Bearish Manner : GMED-US : September 14, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Globus Medical, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)

  • See what the IHS Markit Score report has to say about Globus Medical Inc.
    Markitlast month

    See what the IHS Markit Score report has to say about Globus Medical Inc.

    Short interest is moderate for GMED with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, ETFs holding GMED are favorable, with net inflows of $3.77 billion.

  • IBD Rating Upgrades: Globus Medical Shows Improved Price Strength
    Investor's Business Dailylast month

    IBD Rating Upgrades: Globus Medical Shows Improved Price Strength

    A Relative Strength Rating upgrade for Globus Medical shows improving technical performance. Will it continue?

  • See what the IHS Markit Score report has to say about Globus Medical Inc.
    Markit2 months ago

    See what the IHS Markit Score report has to say about Globus Medical Inc.

    Short interest is moderate for GMED with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, growth of ETFs holding GMED is favorable, with net inflows of $4.67 billion.

  • Capital Cube2 months ago

    ETFs with exposure to Globus Medical, Inc. : August 21, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Globus Medical, Inc. Here are 5 ETFs with the largest exposure to GMED-US. Comparing the performance and risk of Globus Medical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Globus Medical's Robotic Guidance System Gets FDA Approval
    Zacks2 months ago

    Globus Medical's Robotic Guidance System Gets FDA Approval

    Positive tidings on the regulatory front have favored Globus Medical (GMED) of late. The company's latest regulatory progress would lend it a competitive edge in the global niche space.

  • See what the IHS Markit Score report has to say about Globus Medical Inc.
    Markit2 months ago

    See what the IHS Markit Score report has to say about Globus Medical Inc.

    Short interest is moderate for GMED with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, ETFs holding GMED are favorable, with net inflows of $2.81 billion.

  • Globus Medical (GMED) Stock is Popping: Here's Why
    Zacks2 months ago

    Globus Medical (GMED) Stock is Popping: Here's Why

    On Thursday, shares of medical device company Globus Medical Inc. (GMED) are popping, up almost 6% in late-morning trading after the firm announced that the FDA granted 510(k) clearance to one of its key products, the robotic guidance and navigation system Excelsius GPS.

  • See what the IHS Markit Score report has to say about Globus Medical Inc.
    Markit2 months ago

    See what the IHS Markit Score report has to say about Globus Medical Inc.

    Short interest is moderate for GMED with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. ETFs that hold GMED had net inflows of $35 million over the last one-month.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of GMED earnings conference call or presentation 2-Aug-17 9:30pm GMT

    Q2 2017 Globus Medical Inc Earnings Call

  • Globus Medical, Inc. :GMED-US: Earnings Analysis: Q2, 2017 By the Numbers : August 10, 2017
    Capital Cube2 months ago

    Globus Medical, Inc. :GMED-US: Earnings Analysis: Q2, 2017 By the Numbers : August 10, 2017

    Categories: Yahoo FinanceGet free summary analysis Globus Medical, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Globus Medical, Inc. – Stryker Corporation, K2M Group Holdings, Inc., Zimmer Biomet Holdings, Inc., NuVasive, Inc., Exactech, Inc., Orthofix International NV and RTI Surgical, Inc. (SYK-US, KTWO-US, ZBH-US, ... Read more (Read more...)

  • IHS Markit Score Update: Drop in demand for ETFs holding Globus Medical Inc is a negative sign for its shares
    Markit2 months ago

    IHS Markit Score Update: Drop in demand for ETFs holding Globus Medical Inc is a negative sign for its shares

    Short interest is moderate for GMED with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding GMED totaled $517 million.

  • See what the IHS Markit Score report has to say about Globus Medical Inc.
    Markit2 months ago

    See what the IHS Markit Score report has to say about Globus Medical Inc.

    Short interest is moderate for GMED with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Investors are committing new capital to ETFs that hold GMED at an increasing rate, with the one-month net inflow having reached $253 million.

  • Associated Press2 months ago

    Globus Medical beats Street 2Q forecasts

    The Audubon, Pennsylvania-based company said it had profit of 29 cents per share. Earnings, adjusted for one-time gains and costs, came to 32 cents per share. The results beat Wall Street expectations. ...

  • Globus Medical Enjoys Another Solid Quarter Thanks to International Sales Growth
    Motley Fool2 months ago

    Globus Medical Enjoys Another Solid Quarter Thanks to International Sales Growth

    The musculoskeletal implant manufacturer gets plenty of help in the second quarter from its 2016 acquisition of Alphatec.

  • Globus Medical, Inc. breached its 50 day moving average in a Bearish Manner : GMED-US : July 31, 2017
    Capital Cube3 months ago

    Globus Medical, Inc. breached its 50 day moving average in a Bearish Manner : GMED-US : July 31, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Globus Medical, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)

  • Investopedia3 months ago

    Short-Term Breakouts Point to Higher Prices in These Stocks

    These stocks are all in uptrends and recently broke out of short-term consolidations, signaling another up wave.

  • Globus Medical, Inc. breached its 50 day moving average in a Bearish Manner : GMED-US : July 19, 2017
    Capital Cube3 months ago

    Globus Medical, Inc. breached its 50 day moving average in a Bearish Manner : GMED-US : July 19, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Globus Medical, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)

  • Should Mazor Robotics' Investors Fear the Incoming Competition?
    Motley Fool3 months ago

    Should Mazor Robotics' Investors Fear the Incoming Competition?

    Mazor Robotics has a commanding lead in the robotic surgical markets for spine and brain procedures, but do investors finally need to start worrying about the competition?